Results 11 to 20 of about 4,816,998 (166)
New Developments in Ocular Surface Squamous Neoplasia
Türk Oftalmoloji Dergisi, 2014 Ocular surface squamous neoplasia originates from conjunctiva epithelium and covers a broad spectrum of disease ranging from dysplasia to squamous cell carcinoma. Clinical features may vary from case to case.
Ayşe Yağcı
doaj +2 more sources
“Interferon magic” in ocular surface squamous neoplasia
Kerala Journal of Ophthalmology, 2018 An elderly patient with limbal growth in the left eye was diagnosed by impression cytology as ocular surface squamous neoplasia (OSSN) and subsequently treated with topical interferon α 2b (IFN-α 2b).
Sinumol Sukumaran Thulaseedharan +3 more
doaj +2 more sources
Limbal Pseudoepitheliomatous Hyperplasia Mimicking Ocular Surface Squamous Neoplasia in Palpebral Vernal Keratoconjunctivitis [PDF]
Case Reports in Ophthalmological Medicine, 2013 Purpose. Pseudoepitheliomatous hyperplasia at the limbus can mimic an ocular surface squamous neoplasia. It is an uncommon manifestation of vernal keratoconjunctivitis and has been reported previously in limbal VKC.
Chintan Malhotra +2 more
doaj +2 more sources
Ocular surface squamous neoplasia in Ibadan, Nigeria
Asian Journal of Oncology, 2015 Introduction: Squamous cell carcinoma is the most common malignancy of the conjunctiva worldwide. Ocular surface squamous neoplasia (OSSN) describes the spectrum of ocular surface intraepithelial neoplasia, pre-invasive and invasive squamous cell ...
Oluyemi Fasina
doaj +2 more sources
Ocular Surface Squamous Neoplasia in Xeroderma Pigmentosum [PDF]
Online Journal of Health & Allied Sciences, 2013 Xeroderma pigmentosum (XP) is a rare genetic disorder associated with multiple oculocutaneous and neurological manifestations. It occurs due to deficiency of the enzymes responsible for repairing ultraviolet radiation-induced DNA damage.
Rajesh R Nayak +5 more
doaj +1 more source
Update on pharmacotherapy for ocular surface squamous neoplasia
Eye and Vision, 2019 The most frequently encountered non-pigmented tumor of the ocular surface is ocular surface squamous neoplasia (OSSN). Over the past two decades, the pharmacological management of OSSN has grown, with topical 5-fluorouracil, mitomycin, and interferon ...
Ghada Al Bayyat +4 more
doaj +2 more sources
Reply: Pigmented ocular surface squamous neoplasia
Kerala Journal of Ophthalmology, 2017 We present a case of a heavily pigmented ocular surface squamous neoplasia (OSSN) in a healthy 58-year-old male with a history of chronic sun exposure. The lesion was 4 mm × 3 mm in size and located in the nasal limbus.
Philip Kuruvilla +1 more
doaj +2 more sources
Masquerade syndrome in ocular surface squamous neoplasia. [PDF]
Arq Bras Oftalmol, 2023 The aim of this study was to alert the ophthalmic community to an atypical manifestation of ocular surface squamous neoplasia, which may delay diagnosis and treatment and result in a guarded visual prognosis and significant sequelae.
Oliveira Cechim RV +5 more
europepmc +2 more sources
An update in the management of ocular surface squamous neoplasia
, 2021 Management of ocular surface squamous neoplasia (OSSN) has been a matter of debate among ocular oncologists. While surgical excision with tissue biopsy has been the gold standard, topical chemotherapy with agents such as interferon-α2b, 5-fluorouracil ...
Kounatidou, Nefeli Eleni +1 more
core +3 more sources
Chronic inflammation as a proposed risk factor for ocular surface squamous neoplasia. [PDF]
Ocul SurfChronic inflammation is a predisposing factor for metaplastic changes and ultimately dysplasia. We describe cases of OSSN occurring in the setting of chronic ocular surface inflammation.
De Arrigunaga S +7 more
europepmc +2 more sources